培養肉原料市場 - 世界および地域別分析：分析と予測（2023年～2028年）

持続可能な代替タンパク質源を求める消費者や食品企業の増加に伴い、培養肉原料市場は食品業界に変革をもたらしています。

培養食肉は、細胞培養肉またはラボグロウンミートとしても知られ、食品業界における先駆的な発展を象徴しています。動物の細胞から直接食肉を生産することで、従来の食肉生産に代わる持続可能で倫理的な選択肢を提供するものです。

世界がより持続可能なタンパク質の選択肢を求める中、培養肉原料は説得力のある解決策を提供します。培養肉は、培養細胞の栄養源として植物由来の原料を使用して生産することができ、従来の畜産への依存を減らすことができます。藻類や微生物は、コスト効率に優れ、持続可能な栄養源として培養食肉に利用できます。

細胞工学は食肉の培養において重要な役割を果たします。動物細胞を効率的に分離・増殖させ、培養食肉のスケーラブルな生産を可能にする革新的技術が開発されています。バイオリアクターは、細胞の増殖に最適な環境を作り出し、大規模な食肉生産を可能にするために不可欠です。

当レポートでは、世界の培養肉原料市場について調査し、市場の概要とともに、製品別、用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場

• 業界の見通し
• ビジネスダイナミクス
• 市場戦略と展開
• ビジネスの機会
• ステークホルダーの分析
• 投資情勢

第2章 用途

• 培養肉原料および装置市場 - （用途別）
• 培養肉原料および装装置市場の需要分析（用途別）

第3章 製品

• 培養肉原料および装置市場 - （製品別）
• 培養肉原料・装置市場の需要分析（製品別）
• サプライチェーン分析/バリューチェーン分析
• 特許分析

第4章 地域

• 世界市場の見通し
• 北米
• 欧州
• アジア太平洋
• その他の地域

第5章 市場-競合ベンチマーキングと企業プロファイル

• 競合ベンチマーキング
  • 競争力マトリックス
  • 市場シェア分析
• 企業プロファイル
  • 原料メーカー
  • 装置メーカー

第6章 調査手法

The Cultured Meat Ingredients Market is experiencing a transformative shift in the food industry, as an increasing number of consumers and food companies seek sustainable and alternative protein sources. This report provides a comprehensive analysis of the Cultured Meat Ingredients Market, focusing on alternate protein sources, cell engineering techniques, and the barriers in the commercialisation of cultivated meat.

Introduction

Cultivated meat, also known as cell-based meat or lab-grown meat, represents a pioneering development in the food industry. It offers a sustainable and ethical alternative to traditional meat production by producing meat directly from animal cells. This report explores the ingredients and technologies that make this innovation possible.

Market Overview

This report provides an overview of the Cultured Meat Ingredients Market, emphasizing its current state and growth prospects.

Market Size and Growth

• Factors driving this growth include increased consumer demand for sustainable and cruelty-free meat products, advancements in cell engineering, and the expanding food-tech industry.

Alternate Protein Sources

As the world seeks more sustainable protein options, cultivated meat ingredients offer a compelling solution.

• Plant-Based Proteins: Cultured meat can be produced using plant-based ingredients as a nutrient source for the cultivated cells, reducing the reliance on traditional livestock farming.

• Algae and Microbes: Algae and microorganisms can serve as a cost-effective and sustainable source of nutrients for cultivated meat, presenting opportunities for ingredient innovation.

Cell Engineering Techniques

Cell engineering plays a crucial role in the cultivation of meat.

• Cell Isolation and Proliferation: Innovative techniques are being developed to isolate and proliferate animal cells efficiently, ensuring the scalable production of cultivated meat.

• Bioreactors: Bioreactors are essential for creating the optimal environment for cell growth, enabling large-scale meat production.

Barriers in the Commercialization of Cultivated Meat

While cultivated meat holds promise, it faces significant challenges on its path to commercialization.

Regulatory Hurdles

• Labelling and Safety Standards: Regulations surrounding labelling, safety, and health standards for cultivated meat need to be established to ensure consumer trust and safety.

• Approval Processes: Streamlining regulatory approval processes is essential to enable the commercialization of cultivated meat products.

Cost and Scalability

• Cost-Effective Production: Reducing the cost of production is vital to make cultivated meat competitive with traditional meat products.

• Scaling Production: Scaling up production while maintaining quality and safety standards is a challenge that needs to be addressed.

Consumer Acceptance

• Cultural Acceptance: Consumer preferences and cultural acceptance of cultivated meat will be crucial for market success.

• Education and Awareness: Initiatives are needed to educate the public about the benefits of cultivated meat and dispel misconceptions.

Table of Contents

1. Markets

• 1.1. Industry Outlook
  • 1.1.1. Market Definition
  • 1.1.2. Alternate Protein Trends
    • 1.1.2.1. Alternate Protein: Current and Future
      • 1.1.2.1.1. Advantages of Alternate Protein in Large-Scale Manufacturing
      • 1.1.2.1.2. Disadvantages of Alternate Protein in Large-Scale Manufacturing
    • 1.1.2.2. Developments in Cell Engineering
    • 1.1.2.3. Exploration of Environmental Benefits of Alternate Protein
    • 1.1.2.4. Emerging Start-ups in the Sector
      • 1.1.2.4.1. Key Countries to Focus
      • 1.1.2.4.2. Research and Development Programs Supported by Governments and Investors
    • 1.1.2.5. Other Industrial Trends
      • 1.1.2.5.1. Hybrid Products
      • 1.1.2.5.2. Fast-Food and Restaurant Partnerships
      • 1.1.2.5.3. Cultured Dairy and Eggs
      • 1.1.2.5.4. Bioinformatics and Data-Driven Approaches
  • 1.1.3. Ecosystem / Ongoing Programs
    • 1.1.3.1. Consortiums and Associations
    • 1.1.3.2. Regulatory Landscape
    • 1.1.3.3. Government Initiatives
  • 1.1.4. Alternate Protein: Cost Analysis

(Note: This section talks about the costs comparison between plant-based, cultivated, and fermented meat alternatives)

• 1.2. Business Dynamics
  • 1.2.1. Business Drivers
  • 1.2.2. Barriers in the Commercialization of Cultivated Meat

(Note: This section covers the scientific/economical/cultural/regulatory barriers faced by Cultured Meat companies)

• 1.2.3. Market Strategies and Developments
  • 1.2.3.1. Business Strategies
    • 1.2.3.1.1. Product Developments
    • 1.2.3.1.2. Market Developments
  • 1.2.3.2. Corporate Strategies
    • 1.2.3.2.1. Mergers & Acquisitions
    • 1.2.3.2.2. Partnerships, Joint Ventures, Collaborations & Alliances
  • 1.2.3.3. Others
• 1.2.4. Business Opportunities

(Note: This segment consists of the analysis of the stakeholders in the Cultured Meat Ingredients and Equipment and equipment market. This will include equipment manufacturers such as Liberation Labs, ingredient manufacturers such as Matrix F.T., and others)

• 1.3. Stakeholder Analysis
• 1.4. Investment Landscape
  • 1.4.1. Key Investors
  • 1.4.2. Major Fundings

2. Application

• 2.1. Cultured Meat Ingredients and Equipment Market - (by Application)
  • 2.1.1. Cultured Meat Ingredients and Equipment Market, by End-User Industry
    • 2.1.1.1. Fermentation
    • 2.1.1.2. Other Alternate Meat Manufacturers
    • 2.1.1.3. Cell Engineering
    • 2.1.1.4. Others

(Note: These are tentative applications. Subject to change as per further research and analysis)

• 2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Application)
  • 2.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by End-User Industry

3. Products

• 3.1. Cultured Meat Ingredients and Equipment Market - (by Product)
  • 3.1.1. Cultured Meat Ingredients and Equipment Market, by Origin
    • 3.1.1.1. Animal-derived (such as Gelatin and Collagen)
    • 3.1.1.2. Plant-derived (such as Cellulose and Alginate)
    • 3.1.1.3. Synthetic (such as Synthetic Peptide Hydrogels)
  • 3.1.2. Cultured Meat Ingredients and Equipment Market, by Type of Starter Cells
    • 3.1.2.1. Skeletal Muscle Stem Cells
    • 3.1.2.2. Fibroblasts
    • 3.1.2.3. Embryonic Stem Cells
    • 3.1.2.4. Others (such as Adipose-Derived Cells, Mesenchymal Stem Cells, and Induced Pluripotent)
• 3.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, (by Product)
  • 3.2.1. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Origin
  • 3.2.2. Demand Analysis of Cultured Meat Ingredients and Equipment Market, by Type of Starter Cell
• 3.3. Supply Chain Analysis/Value Chain Analysis

(Note: The report will cover either the Supply Chain Analysis or Value Chain Analysis, depending upon data availability)

• 3.4. Patent Analysis

4. Region

• 4.1. Global Alternate Protein Outlook
• 4.2. North America
  • 4.2.1. North America (by Country)
    • 4.2.1.1. U.S.
    • 4.2.1.2. Canada
    • 4.2.1.3. Rest-of-North America
• 4.3. Europe
  • 4.3.1. Europe (by Country)
    • 4.3.1.1. Netherlands
    • 4.3.1.2. Israel
    • 4.3.1.3. Germany
    • 4.3.1.4. France
    • 4.3.1.5. Rest-of-Europe
• 4.4. U.K.
• 4.5. China
• 4.6. Asia-Pacific
  • 4.6.1. Asia-Pacific (by Country)
    • 4.6.1.1. Japan
    • 4.6.1.2. South Korea
    • 4.6.1.3. Singapore
    • 4.6.1.4. Rest-of-Asia-Pacific
• 4.7. Rest-of-the-World
  • 4.7.1. Rest-of-the-World (by Region)
    • 4.7.1.1. South America
    • 4.7.1.2. Middle East and Africa
      • 4.7.1.2.1. Israel

5. MARKETS -Competitive Benchmarking & Company Profiles

• 5.1. Competitive Benchmarking
  • 5.1.1. Competitive Position Matrix
  • 5.1.2. Market Share Analysis
    • 5.1.2.1. Ingredient Manufacturers
    • 5.1.2.2. Equipment Manufacturers
• 5.2. Company Profiles
  • 5.2.1. Ingredient Manufacturers
    • 5.2.1.1. AMSBIO
      • 5.2.1.1.1. Company Overview
      • 5.2.1.1.2. Product Portfolio
      • 5.2.1.1.3. Customer Profile
        • 5.2.1.1.3.1. Key Customers
        • 5.2.1.1.3.2. Target Customers
      • 5.2.1.1.4. Analyst View

Note: Similar Details will be provided for below mentioned companies.

• 5.2.1.2. Bright Biotech
• 5.2.1.3. BioBetter
• 5.2.1.4. Extracellular
• 5.2.1.5. IntegriCulture Inc.
• 5.2.1.6. Matrix F.T.
• 5.2.1.7. SeaWith Inc.
• 5.2.1.8. Sartorius AG
• 5.2.1.9. Multus Biotechnology

• 5.2.2. Equipment Manufacturers
  • 5.2.2.1. CELLULAR AGRICULTURE LTD
  • 5.2.2.2. Liberation Labs
  • 5.2.2.3. Prolific Machines

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
• 6.2. Data Triangulation
• 6.3. Market Estimation & Forecast
  • 6.3.1. Factors for Data Prediction and Modelling